British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe COVID-19 symptoms, with the manufacturer saying it “retains activity”...
A clinical trial that examined the use of anti-viral medicine Sotrovimab in the treatment of mild to moderate COVID-19 cases among high-risk patients in the United...